

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Pertuzumab iyikhambi lomdlavuza eliqondiwe elisiza ukulwa nezinhlobo ezithile zomdlavuza webele. Lolu uhlobo lomuthi wokwelapha ngomzimba olusebenza ngokuvimba amaprotheni athile asiza amaseli omdlavuza ukuthi akhule futhi asakale.
Lo muthi unikezwa njalo ngomugqa we-IV (intravenous) esibhedlela noma emtholampilo. Awusoze wathatha lo muthi ekhaya, njengoba udinga ukugadwa ngokucophelela kwezokwelapha nokuqapha ngaso sonke isikhathi sokwelashwa.
I-Pertuzumab iyikhambi le-monoclonal antibody elenzelwe ukulwa nomdlavuza webele we-HER2-positive. Cabanga ngayo njengokhiye oqondile kakhulu ovulela amaprotheni athile kumaseli omdlavuza, uwavimbele ukuthi angakhuli.
Lo muthi ungowodwa ohlwini lwemithi ebizwa ngokuthi ama-HER2 antagonists. Yenziwe elabhorethri ukulingisa amaprotheni emvelo omzimba wakho wokuzivikela, kodwa ngomsebenzi oqondile kakhulu: ukuthola nokunamathela kuma-HER2 receptors kumaseli omdlavuza.
Umuthi usebenza ngokuvimba izimpawu ezitshela amaseli omdlavuza ukuthi aphindaphindeke futhi asakale. Ngokuphazamisa lezi zimpawu zokukhula, i-pertuzumab isiza ukunciphisa noma ukumisa ukuqhubeka komdlavuza webele we-HER2-positive.
I-Pertuzumab isetshenziselwa ngokuqondile ukwelapha umdlavuza webele we-HER2-positive kubantu abadala. Lokhu kusho ukuthi amaseli akho omdlavuza anamaprotheni amaningi e-HER2, okwenza akhule ngokushesha kunamaseli ebele avamile.
Udokotela wakho uzosebenzisa lo muthi ngokuhlanganyela neminye imithi yomdlavuza, ngokuvamile i-trastuzumab kanye ne-chemotherapy. Akuvamile ukusetshenziswa yodwa ngoba ukwelashwa okuhlanganisiwe kuvame ukusebenza kahle ezinhlotsheni ezinolaka zomdlavuza.
Umuthi uvunyelwe izigaba ezahlukene zomdlavuza webele we-HER2-positive. Lokhu kuhlanganisa umdlavuza webele wesigaba sokuqala ngaphambi kokuhlinzwa, umdlavuza webele othuthukile, kanye namacala lapho umdlavuza usakazekela ezingxenyeni zomzimba wakho.
I-Pertuzumab isebenza ngokuvimba indlela yamaprotheni e-HER2 esetshenziswa amaseli omdlavuza ukukhula nokuhlukanisa. Ithathwa njengokwelashwa okuqondiswe ngamandla aphakathi nendawo okuhlasela ngqo amaseli omdlavuza ngenkathi ishiya iningi lamaseli anempilo yedwa.
Umuthi unamathisela engxenyeni ehlukile yamaprotheni e-HER2 kunezinye izidakamizwa ezifanayo njenge-trastuzumab. Le ndlela yokuvimba kabili yenza kube nzima ngamaseli omdlavuza ukuthola izindlela zokuqhubeka nokukhula.
Uma i-pertuzumab isithathe amaprotheni e-HER2, ivimbela amaseli omdlavuza ukuthi angatholi izimpawu "zokukhula nokuphindaphinda" abazidingayo. Le nqubo futhi isiza amasosha akho omzimba ukuthi aqaphele futhi ahlasela amaseli omdlavuza ngempumelelo.
I-Pertuzumab ihlale inikezwa njenge-IV infusion esibhedlela noma esikhungweni sokwelashwa komdlavuza. Awukwazi ukuthatha lo muthi ekhaya, njengoba udinga ukugadwa kwezokwelapha okuchwepheshile kanye nemishini ekhethekile.
Umthamo wakho wokuqala uzonikezwa kancane kancane cishe imizuzu engama-60, nethimba lakho lezempilo likubuka ngokucophelela nganoma yiziphi izindlela. Uma ukubekezelela kahle umthamo wokuqala, imithamo yesikhathi esizayo ivame ukuthatha imizuzu engama-30 kuya kwengama-60.
Ngokuvamile uzothola ukwelashwa njalo ngemva kwamaviki amathathu, nakuba udokotela wakho engase alungise lolu hlelo ngokusekelwe endleleni ozosabela ngayo. Ngaphambi kwe-infusion ngayinye, ithimba lakho lezokwelapha lizohlola izimpawu zakho ezibalulekile futhi libuze nganoma yimaphi imiphumela emibi oyitholile.
Awudingi ukudla noma ukugwema ukudla okuthile ngaphambi kokwelashwa, kodwa ukuhlala unamanzi kahle kungasiza umzimba wakho ukuthi ubhekane nomuthi kangcono. Ithimba lakho lezempilo lizokunikeza imiyalelo ethile mayelana nokudla nokuphuza ngaphambi kokuqokwa kwakho.
Ubude bokwelashwa nge-pertuzumab busekelwe ohlotsheni lwakho oluthile nesigaba somdlavuza webele. Abantu abaningi bathola ukwelashwa izinyanga eziningana kuya ngaphezu konyaka owodwa, kodwa udokotela wakho uzokwenza uhlelo lokwelashwa olwenzelwe wena.
Ngesifo somdlavuza wamabele osaqala, ukwelashwa kuvame ukuthatha cishe unyaka owodwa wonke, okuhlanganisa nesikhathi ngaphambi nangemva kokuhlinzwa. Ngesifo somdlavuza wamabele esithuthukile noma esisabalalayo, ukwelashwa kungaqhubeka uma nje imithi isebenza futhi uyayithola kahle.
Udokotela wakho uzohlola njalo ukuthi ukwelashwa kusebenza kahle kangakanani ngokuhlola igazi, ukuskena ngemifanekiso, nokuhlolwa komzimba. Bazolungisa uhlelo lwakho lokwelashwa ngokusekelwe ekutheni umdlavuza wakho uphendula kanjani nokuthi uzizwa kanjani sekukonke.
Njengayo yonke imithi yomdlavuza, i-pertuzumab ingabangela imiphumela engemihle, nakuba kungewona wonke umuntu oyitholayo. Imiphumela eminingi engemihle ingalawulwa ngokunakekelwa okufanele kwezokwelapha nokusekelwa.
Nawa amanye imiphumela engemihle ongase uyithole, futhi kubalulekile ukukhumbula ukuthi ithimba lakho lezempilo lilungele ukukusiza ukulawula noma yikuphi kwalokhu:
Ithimba lakho lezokwelapha lizokuqapha eduze ngale miphumela engemihle futhi linikeze imithi noma amasu okusiza ukuphatha yona. Abantu abaningi bathola ukuthi imiphumela engemihle iba lula ukuyilawula njengoba umzimba wabo ujwayela ukwelashwa.
Kukhona neminye imiphumela engemihle engavamile kodwa ebucayi kakhulu okuzoqashelwa yithimba lakho lezempilo. Lokhu kudinga ukunakekelwa kwezokwelapha ngokushesha, kodwa akuvamile:
Udktela wakho uzoqhuba izivivinyo ezijwayelekile zomsebenzi wenhliziyo kanye nomsebenzi wegazi ukuze abambe noma yimaphi amaphutha amakhulu ngokushesha. Uma uhlangabezana nanoma yiziphi izimpawu ezikhathazayo phakathi kokwelashwa, xhumana nethimba lakho lezempilo ngokushesha.
I-Pertuzumab ayifanele wonke umuntu, futhi udokotela wakho uzobuyekeza ngokucophelela umlando wakho wezokwelapha ngaphambi kokuqala ukwelashwa. Umuthi usetshenziselwa kuphela umdlavuza webele we-HER2-positive, ngakho ngeke ubhalwe uma umdlavuza wakho ungenayo le phrotheni ethile.
Ngeke ube ngumuntu ofanelekayo ukuthatha i-pertuzumab uma unezinkinga ezinkulu zenhliziyo. Umuthi ungathinta ukusebenza kwenhliziyo, ngakho udokotela wakho uzokwenza izivivinyo zenhliziyo ngaphambi kokuqala ukwelashwa ukuze aqiniseke ukuthi kuphephile kuwe.
Uma ukhulelwe noma uhlela ukukhulelwa, i-pertuzumab ayinconyelwe njengoba ingalimaza umntwana ongakazalwa. Udokotela wakho uzoxoxa ngezindlela zokulawula inzalo ezisebenzayo uma unomlando wokuzala.
Abantu abanezinkinga ezinzima zezinso noma isibindi bangase badinge ukulungiswa komthamo noma bangase bangakwazi ukuthatha lo muthi. Udokotela wakho uzoqhuba izivivinyo zegazi ukuze ahlolisise ukusebenza kwezitho zakho ngaphambi kokuqala ukwelashwa.
Igama lomkhiqizo le-pertuzumab yi-Perjeta, ekhiqizwa yi-Genentech. Leli yilona kuphela igama lomkhiqizo elitholakalayo lalo muthi othile e-United States.
Njengamanje, azikho izinhlobo ezivamile ze-pertuzumab ezitholakalayo. Njengoba lokhu kuyimithi eyinkimbinkimbi ye-biologic, kuthatha isikhathi eside ukuthi izinhlobo ezivamile zithuthukiswe futhi zivunyelwe uma ziqhathaniswa namaphilisi endabuko.
Inkampani yakho yomshuwalense nethimba lezempilo zizosebenzisana ukusiza ukwenza lo muthi utholakale kuwe, njengoba ubhekwa njengokwelashwa okujwayelekile komdlavuza webele we-HER2-positive.
Ngenkathi i-pertuzumab ivame ukuthathwa njengezinga eliphezulu lokwelashwa komdlavuza webele we-HER2-positive, zikhona ezinye izinketho zokwelapha ezihloswe ngazo. Kodwa-ke, lezi akudingeki ukuthi zibe yizithako eziqondile, njengoba ukwelashwa okuhlanganisiwe kuvame ukusebenza kahle kakhulu.
I-Trastuzumab (Herceptin) ngomunye umuthi oqondiswe ku-HER2 ovame ukusetshenziswa kanye ne-pertuzumab. Abanye abantu bangase bathole i-trastuzumab yodwa noma ngokuhlanganiswa neminye imithi uma i-pertuzumab ingabafaneli.
Imithi emisha efana ne-trastuzumab deruxtecan (Enhertu) noma i-tucatinib (Tukysa) ingase ibe yizinketho zezimo ezithile, ikakhulukazi uma umdlavuza usuthuthuke kwezinye izindlela zokwelapha. Udokotela wakho we-oncologist uzoqoka indlela engcono kakhulu yokwelapha ngokusekelwe ezimweni zakho ezithile.
I-Pertuzumab ne-trastuzumab zisebenza kangcono uma zihlangene kunoma iyiphi imithi yodwa. Abawona ukwelashwa okuncintisanayo kodwa kunalokho ukwelashwa okwengezelelana okuhlose izingxenye ezihlukene zendlela efanayo yephrotheni ye-HER2.
Izifundo zikhombisile ukuthi ukusebenzisa i-pertuzumab kanye ne-trastuzumab ndawonye kuthuthukisa imiphumela uma kuqhathaniswa nokusebenzisa i-trastuzumab yodwa. Le ndlela yokuhlanganisa isibe yizinga lokunakekelwa kwabantu abaningi abanomdlavuza webele we-HER2-positive.
Udokotela wakho cishe uzoncoma yomibili imithi ndawonye, kanye ne-chemotherapy, njengoba lokhu kuhlanganiswa kathathu kukhombise imiphumela emihle kakhulu ezivivinyweni zomtholampilo. Isinqumo asikhona mayelana nokukhetha esinye ngaphezu kwesinye, kodwa mayelana nokuzisebenzisa ngamasu ndawonye.
I-Pertuzumab ingathinta ukusebenza kwenhliziyo, ngakho-ke abantu abanezinkinga zenhliziyo ezikhona badinga ukuqapha okwengeziwe. Udokotela wakho uzoqhuba izivivinyo zokusebenza kwenhliziyo ngaphambi kokuqala ukwelashwa futhi njalo ngesikhathi sokwelashwa kwakho.
Uma unezinkinga ezincane zenhliziyo, kungenzeka usakwazi ukuthola i-pertuzumab ngokuqapha okuseduze kwenhliziyo. Kodwa-ke, uma unenhliziyo ehlulekayo enkulu noma ezinye izimo zenhliziyo ezingathi sína, udokotela wakho angase ancome ezinye izindlela zokwelapha.
Izindaba ezinhle ukuthi imiphumela emibi ehlobene nenhliziyo ivame ukubuyiseka uma itholwe kusenesikhathi. Ithimba lakho lezokwelapha lizobheka ukusebenza kwenhliziyo yakho ngokucophelela futhi lingashintsha noma lime ukwelashwa uma kudingeka.
Njengoba i-pertuzumab inikezwa ngaso sonke isikhathi endaweni yezokwelapha ngabasebenzi abaqeqeshiwe, ukweqisa ngengozi akuvamile kakhulu. Umuthi ubhalwa ngokucophelela ngokuya ngesisindo somzimba wakho futhi unikezwa ngokufakwa kwe-IV okulawulwayo.
Uma ukhathazekile ngomthamo wakho noma uhlangabezana nezimpawu ezingavamile ngesikhathi noma ngemva kokwelashwa, tshela ithimba lakho lezempilo ngokushesha. Bangakuqapha ngokuseduze futhi banikeze ukunakekelwa okusekelayo uma kudingeka.
Ithimba lakho lezokwelapha linezinqubo zokuvimbela amaphutha okulinganisa, okuhlanganisa ukuhlola kabili izibalo nokusebenzisa amasistimu okuphepha ekuphathweni kwemithi ye-IV.
Uma uphuthelwa i-aphoyintimenti ye-pertuzumab ehleliwe, xhumana nethimba lakho lokunakekelwa komdlavuza ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Bazonquma indlela engcono kakhulu yokukubuyisela emgqeni ngohlelo lwakho lokwelapha.
Ukuphuthelwa umthamo owodwa ngokuvamile ngeke kube nomthelela omkhulu ekwelashweni kwakho, kodwa kubalulekile ukugcina isimiso sakho esivamile uma kungenzeka. Udokotela wakho angase ashintshe kancane umugqa wesikhathi sokwelashwa kwakho ukuze kuhambisane nomthamo ophuthelwe.
Ungazami ukwenza umthamo ophuthelwe ngokuhlela ukwelashwa eduze. Umzimba wakho udinga isikhathi phakathi kwemithamo ukuze ululame futhi uphendule kahle emuthini.
Kufanele uyeke kuphela ukwelashwa nge-pertuzumab ngaphansi kwesiqondiso sikadokotela wakho. Isinqumo sokuyeka sincike ezintweni eziningana, okuhlanganisa ukuthi umdlavuza wakho usabela kahle kangakanani nokuthi yiziphi imiphumela emibi oyitholayo.
Ngemdlavuza webele wesigaba sokuqala, ukwelashwa ngokuvamile kunosuku lokuphela oluhleliwe ngemuva konyaka owodwa. Ngomdlavuza othuthukile, ukwelashwa kungaqhubeka uma nje kusebenza futhi ukukuthola kahle.
Udokotela wakho uzohlola njalo ukuthi ngabe ukuqhubeka nokwelashwa kuyakuzuzisa yini. Bazocabangela izinto ezinjengokuqhubeka komdlavuza, imiphumela emibi, kanye nekhwalithi yakho yempilo iyonke lapho benza lesi sinqumo.
Abantu abaningi bayakwazi ukuqhubeka nokusebenza ngesikhathi sokwelashwa nge-pertuzumab, yize kungadingeka ukuthi ulungise isimiso sakho ngokuya ngokuqokwa kokufakwa kanye nokuphatha ukukhathala noma eminye imiphumela emibi.
Ukuqokwa kokwelashwa kuvame ukuthatha amahora ambalwa njalo emavikini amathathu, ngakho-ke uzodinga ukuhlela isikhathi sokungasebenzi ngalezi zikhathi. Abanye abantu bazizwa bekhathele usuku noma ezimbili ngemuva kokwelashwa, kanti abanye bazizwa kahle.
Xoxa nomqashi wakho mayelana nokuhlelwa komsebenzi okuguquguqukayo uma kudingeka. Abantu abaningi bathola ukuthi bangagcina imisebenzi yabo ejwayelekile ngokuguqulwa okuthile ngesikhathi sokwelashwa.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.